课题基金 / 基金详情

ESTABLISHMENT OF AIDS CLINICAL TRIALS UNIT

ESTABLISHMENT OF AIDS CLINICAL TRIALS UNIT
艾滋病临床试验单位的建立
批准号:
3547445
负责人:
RUY SOEIRO
金额:
$163.13万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-06-30 至 1995-12-31

项目摘要

项目成果

RUY SOEIRO的其他基金

相似基金

相关文献

中文摘要
翻译
本赠款申请(RFA)是为了建立(继续)一个 成人临床试验计划,用于测试药物治疗 HIV-1感染者。 审判的主要目的是 II/III期方案,以测试较新类型和组合的功效, 抗病毒药物,以确定最佳的方法来治疗早期(通常 无症状),后来,(具有显著的免疫功能低下状态)HIV(+) 患者,以及对目前接受的治疗不耐受的患者。 在 此外,新药剂和药剂组合的治疗方案 机会性感染、恶性肿瘤和相关的神经系统疾病 将进行临床试验。 药物药理学:开发新的测定方法, AZT的细胞内水平,以了解乙酰化动力学的作用 艾滋病患者对磺胺类药物的不耐受。 医学免疫学:细胞免疫学中可溶性细胞标志物的协调 通过细胞内HIV-1的流式细胞术测定病毒表达的活化 第24页。 寄生虫学:生长研究,聚合酶检测 链反应与微孢子虫病的治疗。
英文摘要
This grant request (RFA) is for the establishment (continuation) of an adult clinical trials program for the testing of drugs for the treatment of patients with HIV-1 infection. The major thrust of the trials will be phase II/III protocols to test efficacy of newer types and combinations of antiviral agents to determine the optimal approach to treat early (often asymptomatic), later, (with significant immunocompromised state) HIV (+) patients, as well as those intolerant to current accepted therapy. In addition, protocols for new agents and combinations of agents to treat opportunistic infections, malignancies, and neurological disease associated with AIDS will undergo clinical trials. DEVELOPMENTAL PHARMACOLOGY: Development of novel assays to measure the intracellular levels of AZT to understand the role of acetylation kinetics in sulfonamide intolerance in AIDS patients. DEVELOPMENTAL IMMUNOLOGY: Coordination of soluble cell markers of cellular activation with virus expression by Flow Cytometry of intracellular HIV-1 p24. DEVELOPMENTAL PARASITOLOGY: Study of the growth, detection by Polymerase Chain Reaction, and therapy of Microsporidiosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE--CLINICAL
CORE--CLINICAL
CORE--CLINICAL
AIDS VIRUS INFECTION OF HUMAN NEURONAL CELLS
海外基金